Irinotecan and Taxane Combinations for Non–Small-Cell Lung Cancer
Murren J, Davies M. Irinotecan and Taxane Combinations for Non–Small-Cell Lung Cancer. Clinical Lung Cancer 2001, 2: s20-s25. PMID: 14725726, DOI: 10.3816/clc.2001.s.004.Peer-Reviewed Original ResearchNon-small cell lung cancerLung cancerAdvanced non-small cell lung cancerDay 1Treatment of NSCLCWeekly scheduleLow-grade gastrointestinal toxicitySmall cell lung cancerPaclitaxel-containing regimenDoses of docetaxelDose-limiting toxicityCell lung cancerEvaluable patientsNonhematologic toxicityStable diseaseGastrointestinal toxicityTaxane combinationsPartial responseProgressive diseaseMild diarrheaPreclinical modelsAdditive cytotoxicityToxicity profileTreatment scheduleChemotherapy